Trial Profile

Phase 1 SAD trial of ZP6590 in healthy volunteers

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 22 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ZP 6590 (Primary)
Indications Obesity
Focus Adverse reactions; First in man

Most Recent Events

17 Aug 2023 According to a Zealand Pharma media release, advance this program into first-in-human clinical trials in the first half of 2024.
08 Mar 2023 New trial record
02 Mar 2023 According to a Zealand Pharma media release, the company expect to initiate this trial in the second half of 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com